Literature DB >> 10814797

Autoimmune T cells retard the loss of function in injured rat optic nerves.

G Moalem1, E Yoles, R Leibowitz-Amit, S Muller-Gilor, F Mor, I R Cohen, M Schwartz.   

Abstract

We recently demonstrated that autoimmune T cells protect neurons from secondary degeneration after central nervous system (CNS) axotomy in rats. Here we show, using both morphological and electrophysiological analyses, that the neuroprotection is long-lasting and is manifested functionally. After partial crush injury of the rat optic nerve, systemic injection of autoimmune T cells specific to myelin basic protein significantly diminished the loss of retinal ganglion cells and conducting axons, and significantly retarded the loss of the visual response evoked by light stimulation. These results support our challenge to the traditional concept of autoimmunity as always harmful, and suggest that in certain situations T cell autoimmunity may actually be beneficial. It might be possible to employ T cell intervention to slow down functional loss in the injured CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814797     DOI: 10.1016/s0165-5728(00)00240-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  Protective autoimmunity is a physiological response to CNS trauma.

Authors:  E Yoles; E Hauben; O Palgi; E Agranov; A Gothilf; A Cohen; V Kuchroo; I R Cohen; H Weiner; M Schwartz
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

Review 3.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

4.  Celastrol supports survival of retinal ganglion cells injured by optic nerve crush.

Authors:  Haksu Kyung; Jacky M K Kwong; Vlad Bekerman; Lei Gu; Daniel Yadegari; Joseph Caprioli; Natik Piri
Journal:  Brain Res       Date:  2015-03-24       Impact factor: 3.252

5.  Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.

Authors:  Jonathan Kipnis; Tal Mizrahi; Ehud Hauben; Iftach Shaked; Ethan Shevach; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

Review 6.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.

Authors:  T Bucky Jones; D Michele Basso; Ajeet Sodhi; Jonathan Z Pan; Ronald P Hart; Robert C MacCallum; Sunhee Lee; Caroline C Whitacre; Phillip G Popovich
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 8.  Pro-cognitive properties of T cells.

Authors:  Jonathan Kipnis; Sachin Gadani; Noël C Derecki
Journal:  Nat Rev Immunol       Date:  2012-08-20       Impact factor: 53.106

9.  A sportomics strategy to analyze the ability of arginine to modulate both ammonia and lymphocyte levels in blood after high-intensity exercise.

Authors:  Adriana Bassini; Luiz-Claudio Cameron; Luis Carlos Gonçalves; Artur Bessa; Ricardo Freitas-Dias; Rafael Luzes; João Pedro Saar Werneck-de-Castro
Journal:  J Int Soc Sports Nutr       Date:  2012-06-26       Impact factor: 5.150

10.  Immune maintenance in glaucoma: boosting the body's own neuroprotective potential.

Authors:  Michal Schwartz; Anat London
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.